It’s here. Our annual flagship report The State of Legal Cannabis Markets is now in its 7th edition. Produced in partnership with BDS Analytics, the report points to abundant growth and unrealized potential in the cannabis markets while underlining the challenges that face the sector.
If you are among the first 100 people to use the code LEGAL7, you will receive $100 off your purchase of the “Industry Bible.”
According to the report, 2018 showed a growth rate of 20% in the global sales of cannabis in regulated markets, with sales on track to surge 36% to $14.9 billion in 2019, and reach $40 billion by 2024.
In 2018, the FDA approved GW Pharmaceutical’s Epidiolex and passed the 2018 Farm Bill legalizing hemp in the United States.
These decisions being made at the federal level put pharmacies and general retailers in the business of selling CBD-based products in all 50 states, which substantially boosted the Total Cannabinoid Market (TCM). In the U.S. alone, sales of CBD products in all channels will hit $20 billion by 2024.
Inside, you’ll find 350+ pages providing the industry’s first current quantification and forecast out to 2024 of the TCM in the U.S. It also includes forecasts of the regulated medical and adult-use markets in each of the cannabis-legalizing countries of the world including, for the first time, province-by-province forecasts of the newly adult-legal Canadian market.
